RCUS Earnings

Quarterly EPS
$-1.00
Q3 2024
$-1.03
Q4 2024
$-1.14
Q1 2025
$0.00
Q2 2025
$-1.27
Q3 2025
$-0.89
Q4 2025
$-1.02
Q1 2026
$-0.72
Q2 2026
Latest Revenue41.0M
Latest Net Income-91000000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.7241.0M-91000000-74.4%
Q1 2026-$1.0217.0M-128000000-39.3%+10.5%
Q4 2025-$0.8933.0M-106000000+26.9%+13.6%
Q3 2025-$1.2726.0M-135000000-45.8%-27.0%
Q2 2025$0.00160.0M0+310.3%+100.0%
Q1 2025-$1.1428.0M-112000000-80.7%-2,180.0%
Q4 2024-$1.0326.0M-94000000-16.1%+4.6%
Q3 2024-$1.0048.0M-92000000+50.0%-6.4%
Q2 2024-$1.0239.0M-93000000
Q1 2024-$0.05145.0M-4000000
Q4 2023-$1.0831.0M-81000000
Q3 2023-$0.9432.0M-71000000
Arcus Biosciences (RCUS) — Earnings